Most cited papers from Finlay Institute

Finlay Institute

What are the most cited papers from Finlay Institute?

The most cited paper from Finlay Institute is "Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba." (G V Sierra, H C Campa, N M Varcacel et al., 1991), with 515 citations. Next come "A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b" (493) and "Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis" (411).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 47 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. G V Sierra, H C Campa, N M Varcacel et al. · PubMed	Dec 1991	515
2	A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b Vicente G. Vérez-Bencomo et al. · Science	22 Jul 2004	493
3	Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis Johan Holst, Diana Martin, Richard Arnold et al. · Vaccine	29 May 2009	411
4	Bacterial Outer Membrane Vesicles and Vaccine Applications Reinaldo Acevedo, Sonsire FernÃ¡ndez, Caridad Zayas et al. · Frontiers in Immunology Open access	24 Mar 2014	256
5	The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations Reinaldo Acevedo et al. · Expert Review of Vaccines Open access	10 Dec 2018	198
6	Unique human immune signature of Ebola virus disease in Guinea Paula Ruibal et al. · Nature Open access	3 May 2016	191
7	Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs Ann Williams, Rajko Reljić, Irene Naylor et al. · Immunology	3 Feb 2004	183
8	2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces Katherine Margaret Berg et al. · Circulation Open access184 authors	9 Nov 2023	158
9	Enterex: Anti-diarrheic drug based on purified natural clinoptilolite Gerardo Rodrı́guez-Fuentes, Mariana Barrios, Antonio Iraizoz et al. · Zeolites	Nov 1997	145
10	Gene Expression and Production of Tumor Necrosis Factor Alpha, Interleukin-1β (IL-1β), IL-8, Macrophage Inflammatory Protein 1α (MIP-1α), MIP-1β, and Gamma Interferon-Inducible Protein 10 by Human Neutrophils Stimulated with Group B Meningococcal Outer Membrane Vesicles José A. Lapinet, Patrizia Scapini, Federica Calzetti et al. · Infection and Immunity Open access	Dec 2000	137
11	Analysis of the distribution of HLA-B alleles in populations from five continents Fionnuala Williams, Ashley Meenagh, Christopher Darke et al. · Human Immunology	Jun 2001	135
12	Characterization of Salmonella‐Induced Filaments (Sifs) Reveals a Delayed Interaction Between Salmonella‐Containing Vacuoles and Late Endocytic Compartments John Hunter Brumell, Patrick Tang, Scott D. Mills et al. · Traffic	Sep 2001	128
13	Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP) Francisco Estevez, Adriana Carr, Leobaldo Solórzano et al. · Vaccine	Aug 1999	121
14	Enhanced Th1 Response to Staphylococcus aureus Infection in Human Lactoferrin-Transgenic Mice C. Guillén, Iain B. McInnes, Diane M. Vaughan et al. · The Journal of Immunology	Apr 2002	99
15	Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens Arístides Aguilar Betancourt et al. · International Journal of Infectious Diseases Open access	25 Jan 2007	98
16	Preliminary Assessment of the Safety and Immunogenicity of a New CTXΦ-Negative, Hemagglutinin/Protease-Defective El Tor Strain as a Cholera Vaccine Candidate Jorge A. Benítez, Luis G. García, Anisia Silva et al. · Infection and Immunity Open access	Feb 1999	98
17	A comparative study between the adsorption of IgY and IgG on latex particles L. Dávalos-Pantoja, Juan Luis Ortega-Vinuesa, Delfi Bastos‐González et al. · Journal of Biomaterials Science Polymer Edition	2000	97
18	The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers Luis Eugenio Valdés García et al. · Infection and Immunity Open access	21 Apr 2005	94
19	Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice Alberto Fachado, Alexandro Rodríguez-Rojas, Sergio Oscar Angel et al. · Vaccine	Mar 2003	92
20	Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control Gustavo G. Bracho, Enrique Varela, Rolando Lloga Fernández et al. · Homeopathy	Jul 2010	91
21	SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies Yury Valdés-Balbín et al. · ACS Chemical Biology	4 Jul 2021	88
22	Effects of Spray Drying on Physicochemical Properties of Chitosan Acid Salts Mirna Fernández Cervera, Jyrki Heinämäki, Nilia de la Paz et al. · AAPS PharmSciTech Open access	10 May 2011	84
23	Bacteriostatic activity of human lactoferrin againstStaphylococcus aureusis a function of its iron-binding properties and is not influenced by antibiotic resistance Antonio Aguila, Ana Gabriela Herrera, Donald A. Morrison et al. · FEMS Immunology & Medical Microbiology Open access	Aug 2001	83
24	Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota Fabrizio Chiodo, Sven C. M. Bruijns, Ernesto Rodríguez et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	14 May 2020	80
25	Efficacy of ozonized sunflower oil in the treatment of tinea pedis Silvia Menéndez, L. Falcón, Didier Simon et al. · Mycoses	Oct 2002	77
26	Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection Yamilé López‐Hernández, Daniel Yero, Gustavo Falero-Díaz et al. · International Journal of Medical Microbiology	21 Jan 2009	75
27	Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction Qingju Zhang, Ana Gimeno, Darielys Santana-Mederos et al. · ACS Central Science Open access	24 Jul 2019	73
28	Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba Raydel Martínez, Alberto Pérez, María del Carmen Quiñones et al. · Revista Panamericana de Salud Pública Open access	Apr 2004	73
29	Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform Oliver A Perez, Belkis Romeu, Osmir Cabrera et al. · Frontiers in Immunology Open access	2013	72
30	Novel adjuvant based on a proteoliposome‐derived cochleate structure containing native lipopolysaccharide as a pathogen‐associated molecular pattern Oliver A Perez, Gustavo G. Bracho, Miriam Lastre et al. · Immunology and Cell Biology	15 Nov 2004	71
31	Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine Oliver A Perez, Miriam Lastre, José A. Lapinet et al. · Infection and Immunity Open access	Jul 2001	70
32	Carcinoid heart disease: diagnosis by two-dimensional echocardiography. Robert Howard, Milutin Drobac, Walter D. Rider et al. · Circulation	Nov 1982	69
33	Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet et al. · ACS Central Science Open access	19 Apr 2021	67
34	Novel parkin mutations detected in patients with early‐onset Parkinson's disease Aida Maria Bertoli‐Avella et al. · Movement Disorders	6 Dec 2004	67
35	Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection Nadine Álvarez, Oscar Otero, Frank Camacho et al. · BMC Immunology Open access	Feb 2013	66
36	Organ Donation After Out-of-Hospital Cardiac Arrest: A Scientific Statement From the International Liaison Committee on Resuscitation Laurie J. Morrison, Claudio Sandroni, Brian E. Grunau et al. · Circulation Open access	8 Aug 2023	65
37	Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma‐Pi 2 diet Francesco Fallucca, Carmen Porrata, Sara Fallucca et al. · Diabetes/Metabolism Research and Reviews	19 Dec 2013	65
38	Cuban Meningococcal BC Vaccine: Experiences & Contributions from 20 Years of Application Franklin Sotolongo, Concepción Campa, Victoria Casanueva et al. · MEDICC Review Open access	2007	61
39	Dry-reagent gold nanoparticle-based lateral flow biosensor for the simultaneous detection of Vibrio cholerae serogroups O1 and O139 Choo Yee Yu, Geik Yong Ang, Ang Lim Chua et al. · Journal of Microbiological Methods	7 May 2011	61
40	Effect of maltodextrins in the water-content–water activity–glass transition relationships of noni (Morinda citrifolia L.) pulp powder María José Fabra, Eliosbel Márquez, Débora Castro et al. · Journal of Food Engineering	2 Oct 2010	61
41	Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine Raquel Gracia, Marco Marradi, Gianluca Salerno et al. · ACS Macro Letters Open access	25 Jan 2018	60
42	Outer membrane vesicles of the VA‐MENGOC‐BC® vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two‐dimensional gel electrophoresis and mass spectrometry Liliam Uli, Lila Castellanos‐Serra, Lazaro Hiram Betancourt et al. · PROTEOMICS	4 May 2006	60
43	Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Jamie F. S. Mann, Reinaldo Acevedo, Judith M. del Campo et al. · Expert Review of Vaccines	18 Dec 2008	59
44	Colloidal stability of IgG- and IgY-coated latex microspheres L. Dávalos-Pantoja, Juan Luis Ortega-Vinuesa, Delfi Bastos‐González et al. · Colloids and Surfaces B Biointerfaces	Feb 2001	59
45	New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1 Óliver Pérez, Miriam Lastre, Osmir Cabrera et al. · Scandinavian Journal of Immunology	16 Jul 2007	59
46	Is cholera disease associated with poverty? Arturo Fontaine Talavera, Ela María Pérez · The Journal of Infection in Developing Countries Open access	Jul 2009	58
47	Intranasal IFNγ extends passive IgA antibody protection of mice againstMycobacterium tuberculosislung infection Rajko Reljić, Simon O Clark, Ann Williams et al. · Clinical & Experimental Immunology Open access	27 Jan 2006	58
48	Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants Sarah L. Morley, Michelle Jayne Cole, CATHERINE A. ISON et al. · The Pediatric Infectious Disease Journal	Nov 2001	58
49	Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice Judith M. del Campo, Madelene Lindqvist, Maribel Cuello et al. · Vaccine	28 Nov 2009	56
50	Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates Yanira Méndez, Janoi Chang, Ana R. Humpierre et al. · Chemical Science Open access	2018	55

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.